Login / Signup

A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase.

Sam GroomNina K BlumAlexandra E ConibearAlexander DisneyRob HillStephen M HusbandsYangmei LiLawrence TollAndrea KliewerStefan SchulzGraeme HendersonEamonn KellyChris P Bailey
Published in: British journal of pharmacology (2020)
Compound 1 is a novel G protein-biased μ agonist that induces substantial rapid receptor desensitisation in mammalian neurons. Surprisingly, Compound 1-induced desensitisation was demonstrated to be GRK dependent despite its G protein bias. Our findings refute the assumption that G protein-biased agonists will evade receptor desensitisation and tolerance.
Keyphrases
  • spinal cord
  • binding protein
  • pain management
  • spinal cord injury
  • high glucose
  • sensitive detection